Does belatacept improve outcomes for kidney transplant recipients? A systematic review

Beneficial Effect of Belatacept on Health-Related Quality of Life and Perceived Side Effects

(2014) Fabienne Dobbels et al.   TRANSPLANTATION

Long-Term Exposure to Belatacept in Recipients of Extended Criteria Donor Kidneys

(2013) B. Charpentier et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Long-Term Belatacept Exposure Maintains Efficacy and Safety at 5 Years: Results From the Long-Term Extension of the BENEFIT Study

(2013) L. Rostaing et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Summary of the US FDA Approval of Belatacept

(2012) P. Archdeacon et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Belatacept: A New Biologic and Its Role in Kidney Transplantation

(2012) Victoria CH Su et al.   ANNALS OF PHARMACOTHERAPY

Improvement in renal function in kidney transplant recipients switched from cyclosporine or tacrolimus to belatacept: 2-year results from the long-term extension of a phase II study

(2012) Josep Grinyo et al.   TRANSPLANT INTERNATIONAL

A Multicenter Experience With Generic Tacrolimus Conversion

(2011) Lisa M. McDevitt-Potter et al.   TRANSPLANTATION

Immunosuppression with Belatacept-Based, Corticosteroid-Avoiding Regimens in De Novo Kidney Transplant Recipients

(2010) R. Ferguson et al.   AMERICAN JOURNAL OF TRANSPLANTATION

A Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT-EXT Study)

(2010) A. Durrbach et al.   AMERICAN JOURNAL OF TRANSPLANTATION

A Phase III Study of Belatacept-based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)

(2010) F. Vincenti et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Long-Term Renal Allograft Survival in the United States: A Critical Reappraisal

(2010) K. E. Lamb et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Switching from Calcineurin Inhibitor-based Regimens to a Belatacept-based Regimen in Renal Transplant Recipients: A Randomized Phase II Study

(2010) L. Rostaing et al.   Clinical Journal of the American Society of Nephrology

Five-Year Safety and Efficacy of Belatacept in Renal Transplantation

(2010) F. Vincenti et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Belatacept-Based Regimens Versus a Cyclosporine A-Based Regimen in Kidney Transplant Recipients: 2-Year Results From the BENEFIT and BENEFIT-EXT Studies

(2010) Christian P. Larsen et al.   TRANSPLANTATION

Epstein-Barr Virus and Posttransplant Lymphoproliferative Disorder in Solid Organ Transplant Recipients

(2009) U. Allen et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Management of Cardiovascular Disease in Renal Transplant Recipients

(2008) A. C. Shirali et al.   Clinical Journal of the American Society of Nephrology